Lauer Wealth LLC Decreases Stake in CVS Health Co. (NYSE:CVS)

Lauer Wealth LLC cut its holdings in CVS Health Co. (NYSE:CVS) by 33.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 8,915 shares of the pharmacy operator’s stock after selling 4,383 shares during the quarter. CVS Health comprises 0.6% of Lauer Wealth LLC’s investment portfolio, making the stock its 25th biggest holding. Lauer Wealth LLC’s holdings in CVS Health were worth $659,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently modified their holdings of the business. Live Oak Investment Partners purchased a new stake in CVS Health during the fourth quarter worth $25,000. Atticus Wealth Management LLC boosted its position in CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares in the last quarter. Cornerstone Planning Group LLC boosted its position in CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 243 shares in the last quarter. PCA Investment Advisory Services Inc. purchased a new stake in CVS Health during the second quarter worth $37,000. Finally, ZRC Wealth Management LLC boosted its position in CVS Health by 400.0% during the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after purchasing an additional 400 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Barclays assumed coverage on CVS Health in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 price target for the company. SVB Leerink assumed coverage on CVS Health in a report on Monday, February 26th. They issued an “outperform” rating and a $88.00 price target for the company. HSBC assumed coverage on CVS Health in a report on Friday, December 22nd. They issued a “buy” rating and a $94.00 price target for the company. Finally, Piper Sandler boosted their price target on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $89.44.

Insider Transactions at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.25% of the company’s stock.

CVS Health Trading Down 1.6 %

NYSE:CVS traded down $1.10 on Friday, hitting $68.64. 7,691,021 shares of the stock were exchanged, compared to its average volume of 9,022,009. The stock has a market cap of $86.52 billion, a PE ratio of 10.63, a PEG ratio of 0.92 and a beta of 0.52. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The stock has a fifty day moving average of $75.85 and a 200-day moving average of $73.74. CVS Health Co. has a fifty-two week low of $64.41 and a fifty-two week high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The company had revenue of $93.81 billion during the quarter, compared to analyst estimates of $90.58 billion. During the same period in the prior year, the firm posted $1.99 earnings per share. The firm’s revenue was up 11.9% on a year-over-year basis. As a group, equities analysts expect that CVS Health Co. will post 8.33 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.88%. The ex-dividend date is Friday, April 19th. CVS Health’s payout ratio is 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.